Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Gains from Investment Securities (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Gains from Investment Securities for 5 consecutive years, with $171000.0 as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities rose 109.45% year-over-year to $171000.0; the TTM value through Mar 2026 reached -$2.7 million, down 542.15%, while the annual FY2025 figure was $9.4 million, 53.37% up from the prior year.
  • Gains from Investment Securities hit $171000.0 in Q1 2026 for Phathom Pharmaceuticals, up from -$5.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $9.7 million in Q2 2025 and bottomed at -$5.3 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $1.3 million, with a median of $171000.0 recorded in 2026.
  • Year-over-year, Gains from Investment Securities plummeted 205500.0% in 2023 and then skyrocketed 6639.38% in 2024.
  • Phathom Pharmaceuticals' Gains from Investment Securities stood at -$1000.0 in 2022, then tumbled by 205500.0% to -$2.1 million in 2023, then skyrocketed by 304.38% to $4.2 million in 2024, then crashed by 226.25% to -$5.3 million in 2025, then surged by 103.22% to $171000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $171000.0, -$5.3 million, and $9.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.